(1R,5R)-2-methyl-5-prop-1-en-2-yl-1-trimethylsilyloxycyclohex-2-ene-1-carbonitrile
C14H23NOSi — CID 11694484
Data last refreshed: (MolForge compound catalog, from PubChem)
About (1R,5R)-2-methyl-5-prop-1-en-2-yl-1-trimethylsilyloxycyclohex-2-ene-1-carbonitrile
(1R,5R)-2-methyl-5-prop-1-en-2-yl-1-trimethylsilyloxycyclohex-2-ene-1-carbonitrile (PubChem CID 11694484) has the molecular formula C14H23NOSi and a molecular weight of 249.43 g/mol. Its IUPAC name is (1R,5R)-2-methyl-5-prop-1-en-2-yl-1-trimethylsilyloxycyclohex-2-ene-1-carbonitrile.
Molecular Properties
| Compound Name | (1R,5R)-2-methyl-5-prop-1-en-2-yl-1-trimethylsilyloxycyclohex-2-ene-1-carbonitrile |
|---|---|
| PubChem CID | 11694484 |
| Molecular Formula | C14H23NOSi |
| Molecular Weight | 249.43 g/mol |
| Exact Mass | 249.15 |
| IUPAC Name | (1R,5R)-2-methyl-5-prop-1-en-2-yl-1-trimethylsilyloxycyclohex-2-ene-1-carbonitrile |
| SMILES | C=C(C)[C@@H]1CC=C(C)[C@](C#N)(O[Si](C)(C)C)C1 |
| InChI | InChI=1S/C14H23NOSi/c1-11(2)13-8-7-12(3)14(9-13,10-15)16-17(4,5)6/h7,13H,1,8-9H2,2-6H3/t13-,14+/m1/s1 |
| InChIKey | BUSYTADWNFTCOZ-KGLIPLIRSA-N |
| XLogP | 4.03 |
| TPSA | 33.02 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 17 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 249.43 |
| LogP ≤ 5 | 4.03 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 11694484 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.